Alnyam Pharmaceuticals (ALNY -1.3%) slips on further dilution as the underwriters of its recent...

|By:, SA News Editor

Alnyam Pharmaceuticals (ALNY -1.3%) slips on further dilution as the underwriters of its recent secondary offering exercise options to purchase an additional 1.2M shares at $20.13. The purchase increases the size of the offering from 8M to 9.2M and boosts the net proceeds to ALNY to $173.8M.